About the Company
We do not have any company description for EYENOVIA, INC. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $EYEN News
Eyenovia (EYEN) Price Target Decreased by 24.29% to 7.21
The average one-year price target for Eyenovia (NasdaqCM:EYEN) has been revised to 7.21 / share. This is an decrease of 24.29 ...
Eyenovia, Inc. (EYEN)
and NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) and Eyenovia, Inc. (Nasdaq: EYEN) announced the signing of a co-promotion agreement to ...
Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities
Company focusing on multi-billion dollar opportunity in pediatric progressive myopia represented by MicroPine, with interim analysis planned for ...
Eyenovia, Inc. (NASDAQ:EYEN) Q4 2023 Earnings Call Transcript
Eyenovia, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and welcome to Eyenovia’s Fourth Quarter ...
Eyenovia Inc (EYEN): A Technical Analysis
Based on Eyenovia Inc (EYEN), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at -1.61. The debt to equity ratio resting at ...
Eyenovia Shares Fall More Than 14% After Company Says It Is Exploring Sale
By Emon Reiser Shares of Eyenovia were on the decline after the commercial-stage ophthalmic company said it was exploring strategic options, including ...
Eyenovia to Feature its Suite of Commercial Products and the Optejet Dispenser at Upcoming National Eyecare Meetings
NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a commercial-stage ophthalmic company, today announced that the company will be conducting demonstrations of its ...
Eyenovia, Inc. (EYEN) Q4 2023 Earnings Call Transcript
Greetings and welcome to Eyenovia’s Fourth Quarter and Full Year 2023 Earnings Call. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow the ...
Eyenovia Announces Updated Strategy and Corporate Priorities to Focus on Shareholder Value Generation and Immediate Commercial Opportunities
1%/2.5% About Eyenovia, Inc. Except for historical information, all the statements, expectations and assumptions contained in this press release are forward-looking statements. Forward-looking ...
Eyenovia Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Loading the latest forecasts...